Literature DB >> 32712802

The crucial role of early-life gut microbiota in the development of type 1 diabetes.

He Zhou1, Lin Sun1, Siwen Zhang1, Xue Zhao1, Xiaokun Gang1, Guixia Wang2.   

Abstract

Early-life healthy gut microbiota has a profound implication on shaping the mucosal immune system as well as maintaining healthy status later in life, especially at the prenatal or neonatal stages, while intestinal dysbiosis in early life is associated with several autoimmune diseases, including type 1 diabetes (T1D). Since the gut microbiome is potentially modifiable, optimizing the intestinal bacterial composition in early life may be a novel option for T1D prevention. In this review, we will review current data depicting the crucial role of early-life intestinal microbiome in the development of T1D and discuss the possible mechanisms whereby early-life intestinal microbiome influences the T1D progression. We also summarize recent findings on environmental factors affecting gut microbiota colonization and interventions that may successfully alter microbial composition to discuss potential means of preventing T1D progression in at-risk children.

Entities:  

Keywords:  Dysbiosis; Gut microbiota; Prevention; Type 1 diabetes

Mesh:

Year:  2020        PMID: 32712802     DOI: 10.1007/s00592-020-01563-z

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  131 in total

Review 1.  Natural history of type 1 diabetes.

Authors:  Peter Achenbach; Ezio Bonifacio; Kerstin Koczwara; Anette-G Ziegler
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

Review 2.  Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Authors:  Youjia Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2017-02-07       Impact factor: 7.658

3.  Development of healthy gut microbiota early in life.

Authors:  Erika Isolauri
Journal:  J Paediatr Child Health       Date:  2012-06       Impact factor: 1.954

Review 4.  Early-life factors contributing to type 1 diabetes.

Authors:  Maria E Craig; Ki Wook Kim; Sonia R Isaacs; Megan A Penno; Emma E Hamilton-Williams; Jennifer J Couper; William D Rawlinson
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

Review 5.  Current understanding of the role of gut dysbiosis in type 1 diabetes.

Authors:  Ahmed M Abdellatif; Nora E Sarvetnick
Journal:  J Diabetes       Date:  2019-04-22       Impact factor: 4.006

6.  An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis.

Authors:  Jun Chen; Kerry Wright; John M Davis; Patricio Jeraldo; Eric V Marietta; Joseph Murray; Heidi Nelson; Eric L Matteson; Veena Taneja
Journal:  Genome Med       Date:  2016-04-21       Impact factor: 11.117

7.  Alterations of the human gut microbiome in multiple sclerosis.

Authors:  Sushrut Jangi; Roopali Gandhi; Laura M Cox; Ning Li; Felipe von Glehn; Raymond Yan; Bonny Patel; Maria Antonietta Mazzola; Shirong Liu; Bonnie L Glanz; Sandra Cook; Stephanie Tankou; Fiona Stuart; Kirsy Melo; Parham Nejad; Kathleen Smith; Begüm D Topçuolu; James Holden; Pia Kivisäkk; Tanuja Chitnis; Philip L De Jager; Francisco J Quintana; Georg K Gerber; Lynn Bry; Howard L Weiner
Journal:  Nat Commun       Date:  2016-06-28       Impact factor: 14.919

Review 8.  Research Advances and Prospects on Mechanism of Sinomenin on Histamine Release and the Binding to Histamine Receptors.

Authors:  Yu-Shi Zhang; Jia-Yin Han; Omer Iqbal; Ai-Hua Liang
Journal:  Int J Mol Sci       Date:  2018-12-24       Impact factor: 5.923

Review 9.  Gastrointestinal Microbiota and Type 1 Diabetes Mellitus: The State of Art.

Authors:  Marilena Durazzo; Arianna Ferro; Gabriella Gruden
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241

10.  The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes.

Authors:  Spiros Fourlanos; Michael D Varney; Brian D Tait; Grant Morahan; Margo C Honeyman; Peter G Colman; Leonard C Harrison
Journal:  Diabetes Care       Date:  2008-05-16       Impact factor: 19.112

View more
  5 in total

1.  Gut microbiota differs in composition between adults with type 1 diabetes with or without depression and healthy control participants: a case-control study.

Authors:  Frank Petrak; Stephan Herpertz; Julia Hirsch; Bonnie Röhrig; Iris Donati-Hirsch; Georg Juckel; Juris J Meier; Sören Gatermann
Journal:  BMC Microbiol       Date:  2022-06-28       Impact factor: 4.465

2.  Maternal heme-enriched diet promotes a gut pro-oxidative status associated with microbiota alteration, gut leakiness and glucose intolerance in mice offspring.

Authors:  Anaïs Mazenc; Loïc Mervant; Claire Maslo; Corinne Lencina; Valérie Bézirard; Mathilde Levêque; Ingrid Ahn; Valérie Alquier-Bacquié; Nathalie Naud; Cécile Héliès-Toussaint; Laurent Debrauwer; Sylvie Chevolleau; Françoise Guéraud; Fabrice H F Pierre; Vassilia Théodorou; Maïwenn Olier
Journal:  Redox Biol       Date:  2022-05-12       Impact factor: 10.787

Review 3.  The Role of the Gut Microbiota in the Pathogenesis of Diabetes.

Authors:  Weronika Bielka; Agnieszka Przezak; Andrzej Pawlik
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

4.  Disordered development of gut microbiome interferes with the establishment of the gut ecosystem during early childhood with atopic dermatitis.

Authors:  Min-Jung Lee; Yoon Mee Park; Byunghyun Kim; In Hwan Tae; Nam-Eun Kim; Marina Pranata; Taewon Kim; Sungho Won; Nam Joo Kang; Yun Kyung Lee; Dong-Woo Lee; Myung Hee Nam; Soo-Jong Hong; Bong-Soo Kim
Journal:  Gut Microbes       Date:  2022 Jan-Dec

5.  Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations.

Authors:  Ali Tootee; Behrouz Nikbin; Ensieh Nasli Esfahani; Babak Arjmand; Hamidreza Aghayan; Mostafa Qorbani; Aziz Ghahari; Bagher Larijani
Journal:  Med J Islam Repub Iran       Date:  2022-04-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.